DaVita
DVA
#2197
Rank
โ‚ฌ7.20 B
Marketcap
100,83ย โ‚ฌ
Share price
0.09%
Change (1 day)
-33.86%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): 8,95ย โ‚ฌ

According to DaVita's latest financial reports the company's current EPS (TTM) is 8,54ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 9,47ย โ‚ฌ an increase over its 2023 EPS that were of 6,54ย โ‚ฌ.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)8,95ย โ‚ฌ-5.48%
20249,47ย โ‚ฌ44.94%
20236,54ย โ‚ฌ27.26%
20225,14ย โ‚ฌ-35.56%
20217,97ย โ‚ฌ44.1%
20205,53ย โ‚ฌ19.7%
20194,62ย โ‚ฌ540.48%
20180,72ย โ‚ฌ-76.07%
20173,01ย โ‚ฌ-19.31%
20163,74ย โ‚ฌ242.52%
20151,09ย โ‚ฌ-62.87%
20142,94ย โ‚ฌ13.43%
20132,59ย โ‚ฌ8.45%
20122,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
12,63ย โ‚ฌ 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
1,63ย โ‚ฌ-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
18,34ย โ‚ฌ 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
8,80ย โ‚ฌ 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA